CSF2RB and pulmonary alveolar proteinosis: Recent research utilizing Csf2rb-/- PAP mice has demonstrated that pioglitazone can increase the expression of ABCG1, enhance cholesterol efflux in AMs, and alleviate pulmonary symptoms in PAP mice (135).